ZNF217 | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 20 of 45 results for "ZNF217"
i
  1. Crystal structure of ZNF217 bound to DNA PDB

    ID: PDB:4IS1

    Description: Zinc finger protein 217/DNA Complex

  2. CTBP/BARS in ternary complex with NAD(H) and RRTGAPPAL peptide PDB

    ID: PDB:2HU2

    Description: C-terminal-binding protein 1 (E.C.1.1.1.-), 9-mer peptide from Zinc finger protein <

  3. Gene-expression profiling of ZNF217-overexpressing MDA-MB-231 cells BioProject

    ID: PRJNA152321

    Keywords: Transcriptome or Gene expression

    Access Type: download

  4. Crystal structure of ZNF217 bound to DNA, P6522 crystal form PDB

    ID: PDB:4F2J

    Description: PROTEIN/DNA Complex

  5. Identification of genes directly regulated by the oncogene ZNF217 using ChIP-chip assays (Promoter Arrays) OmicsDI

    ID: E-GEOD-6625

    Date Released: 05-02-2014

    Description: It has been proposed that ZNF217, which is amplified at 20q13 in various tumors, plays a key role during neoplastic transformation. ZNF217...

  6. Transcription profiling by high throughput sequencing of ZNF217 chromatin occupancy in the breast cancer cell genome OmicsDI

    ID: E-GEOD-58326

    Date Released: 03-02-2016

    Description: Background: The ZNF217 gene, encoding a C2H2 zinc finger protein, is located at 20q13 and ...

  7. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha BioProject

    ID: PRJNA251998

    Keywords: Transcriptome or Gene expression

    Access Type: download

  8. Identification of genes directly regulated by the oncogene ZNF217 using ChIP-chip assays (Promoter Arrays) ArrayExpress

    ID: E-GEOD-6625

    Description: It has been proposed that ZNF217, which is amplified at 20q13 in various tumors, plays a key role during neoplastic transformation. ZNF217...

  9. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression BioProject

    ID: PRJNA132345

    Keywords: Transcriptome or Gene expression

    Access Type: download

  10. ZNF217 is an oncogene that promotes a basal phenotype and expansion of a progenitor cell population during breast cancer progression BioProject

    ID: PRJNA167151

    Keywords: Transcriptome or Gene expression

    Access Type: download

  11. Crystal structure of ZNF217 bound to DNA PDB

    ID: PDB:3UK3

    Description: PROTEIN/DNA Complex

  12. ZNF217 is an oncogene that promotes a basal phenotype and expansion of a progenitor cell population during breast cancer progression OmicsDI

    ID: E-GEOD-38047

    Date Released: 05-24-2015

    Description: tes with poor prognosis. The transcription factor ZNF217 is a candidate oncogene in 20q13. Patients with breast tumors expressing high ZNF217 had reduced survival and increased resistance to chemotherapy. Inducible Znf217 expr...

  13. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression OmicsDI

    ID: E-GEOD-24727

    Date Released: 05-02-2014

    Description: The transcription factor ZNF217 is a candidate oncogene in the amplicon on chromosome 20q13 that occurs in 20-30% of primary human breast cancers and that c...

  14. Transcription profiling by high throughput sequencing of ZNF217 chromatin occupancy in the breast cancer cell genome ArrayExpress

    ID: E-GEOD-58326

    Description: Background: The ZNF217 gene, encoding a C2H2 zinc finger protein, is located at 20q13 and ...

  15. ZNF217 is an oncogene that promotes a basal phenotype and expansion of a progenitor cell population during breast cancer progression ArrayExpress

    ID: E-GEOD-38047

    Description: tes with poor prognosis. The transcription factor ZNF217 is a candidate oncogene in 20q13. Patients with breast tumors expressing high ZNF217 had reduced survival and increased resistance to chemotherapy. Inducible Znf217 expr...

  16. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression ArrayExpress

    ID: E-GEOD-24727

    Description: The transcription factor ZNF217 is a candidate oncogene in the amplicon on chromosome 20q13 that occurs in 20-30% of primary human breast cancers and that c...

  17. Gene-expression profiling of ZNF217-overexpressing MDA-MB-231 cells OmicsDI

    ID: E-GEOD-35511

    Date Released: 02-15-2012

    Description: n overview of the cellular functions regulated by ZNF217 signaling in breast-cancer cell lines, we performed global gene-expression profiling on MDA-MB-231-pcDNA6 and MDA-MB-231-

  18. Gene-expression profiling of ZNF217-overexpressing MDA-MB-231 cells ArrayExpress

    ID: E-GEOD-35511

    Description: n overview of the cellular functions regulated by ZNF217 signaling in breast-cancer cell lines, we performed global gene-expression profiling on MDA-MB-231-pcDNA6 and MDA-MB-231-

  19. Crystal structure of the Snu23-Prp38-MFAP1(217-296) complex of Chaetomium thermophilum PDB

    ID: PDB:5F5V

    Description: Prp38, Putative uncharacterized protein, Zinc finger domain-containing protein...

  20. An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response [miRNA-seq] ArrayExpress

    ID: E-GEOD-78168

    Description: estrogen response, in part through suppression of ZNF217—an oncogene that is frequently amplified in cancer. We confirmed experimentally that miR-503 directly targets ZNF217 and that over-expression of miR-503 suppresses breast cancer cell proliferation. Overall, these data indicate that miR-503 acts as a potent estrogen-induced tumor suppressor microRNA that opposes cellular proliferation and has promise as a therapeutic for breast cancer. More generally, our work provides a systems-level framework for identifying functional interactions that shape the temporal dynamics of gene expression. Quantification of miRNAs in MCF7 cells responding to estrogen following a period of estrogen starvation. Three independent biological replicates (30 samples: 3 replicates x 10 time points) of MCF7 cells were exposed to 10nM Estradiol for 0, 1, 2, 3, 4, 5, 6, 8, 12 , or 24 hours, and total RNA was extracted from the samples. Total RNA was used to generate paired RNA and miRNA sequencing. The miRNA libraries were prepared using the Bioo Scientific NextFLEX v2 library preparation kit....


Displaying 20 of 45 results for "ZNF217"